osteoarthritis and hip joint degeneration
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Painful, low-grade osteoarthritis of the hip (Kellgren-Lawrence graad I-II) Above 50 years old Synovitis confirmed with ultrasound imaging Ability and willingness to follow instructions and to return for follow-up evaluations
Exclusion criteria
Exclusion criteria: Patients diagnosed with reumathoid arthritis Patients with osseous metastasis Patients with rheumatoid factor > 20 kU/l or blood sedimentation rate > 20mm Patients with a moderate or severe osteoarthritis grade (Kellgren-Lawrence graad III-IV) Patients with a hip/spine dilemma Prostethic implant in the affected joint Not able or willing to undergo bone scintigraphy or blood sampling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objectives Primary objective. •To determine the effect of LDRT on pain sensation after 1,2, 3 and 6 months in early osteoarthritis of the hip, measured with a Visual Analogue Scale (VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives •To determine the effect of LDRT on patient reported outcome measures (PROM) including WOMAC and Oxford Hip Score. •To determine the effect of LDRT on quality of life, assessed through the EuroQoL-5D questionnaire. •To investigate the relationship between effect of LDRT and level of synovitis, measured through ultrasound, bone scintigraphy and blood BSE level. | — |
Countries
Netherlands